Availability, safety and quality of blood products: revision of draft resolution considered by the Executive Board at its 125th session reflecting comments and proposals made by Bangladesh Brazil, Chile, China, India, Japan, New Zealand, Nigeria, Paraguay, Republic of Moldova, and United Kingdom of Great Britain and Northern Ireland

document
document